Esophageal Cancer in Khorasan, Iran


1 Varastegan University of Medical Sciences, Mashhad, Iran

2 Cancer Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.


Context: Iran has been known as one of the most common areas of esophageal cancer in the world. Actually, North of Iran is well known as a high-incidence endemic region located on the belt of esophagus cancer which is extended from the north of China to the south of Caspian Sea. Evidence Acquisition: This paper is going to have an overview on the esophageal cancer in Iran through reviewing the results of some new researches have been completed in recent years in Khorasan, Iran. Results: Epidemiology of esophageal cancer has been changing in recent years in Khorasan, Iran and the incidence rate of the disease is declining. Although the exact reasons for the high incidence rate and yet for declining incidence of the disease are not known, there has been some points of view for this evolution. Still the great majority of esophageal cancers are squamous cell carcinoma and the females and males are almost equally involved in the disease. The most interesting aspect of the disease in this region is long survival of most of the patients. Conclusion: It seems there are some differences in esophageal cancer disease between Iran and other countries especially western onesin terms of the etiologic risk factors of the disease, some of its epidemiologic aspects, as well as outcome of the disease which seems to be better in Iran.


  1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11. Lyon, France: International Agency for Research on Cancer; 2013.
  2. Iranian annual of national cancer registration report. Tehran: Ministry of Health and Medical Education; 2008.
  3. Parkin DM, Muir CS. Cancer incidence in five continents. Comparability and quality of data. IARC Sci Publ. 1992;120:45- 173. [PubMed: 284606].
  4. Munos N, Day NE. Esophageal cancer; in cancer epidemiology and prevention. 2nd ed. Oxford: Oxford University Press; 1996. P. 681-706.
  5. Posner MC, Minsky BD, Ilson DH. Cancer of the esophagus. In: Frogge MH, Goodman DM, Yarbro CH, editors. Cancer principles and practice of oncology. 10th ed. Philadelphia: Lippincott Williams & Wilkins; 2015. P. 574-612.
  6. Salek R, Bezenjani SE, Saedi HS, Ashkiki MH, Hosainzade SM, Mohtashami S, et al. A geographic area with better outcome of esophageal carcinoma: is there an effect of ethnicity and etiologic factors? Oncology. 2009;77(3-4):172-7. doi: 10.1159/ 000231887. [PubMed: 19641336].
  7. Cook-Mozaffari PJ, Azordegan F, Day NE, Ressicaud A, Sabai C, Aramesh B. Oesophageal cancer studies in the Caspian Littoral of Iran: Results of a case-control study. Br J Cancer. 1979;39(3):293-309. doi: 10.1038/bjc.1979.54. [PubMed:465299].
  8. Moradi A, Villiers EM, Mokhtari-Azad T, Mahmoudi M, Hazrati B, Ghaemi EE, et al. Detection of human papillomavirus DNA by PCR in esophageal squamous cell cancer for Turkman-Sahra, North east of Iran. Iran Biomed J. 2002;6(1):19-23.
  9. Sadeghi A, Marjani H, Semnani S, Nasseri-Moghaddam S. Esophageal cancer in Iran: a review. Middle East J Cancer. 2010;1(1):5-14.
  10. Zang HZ, Jin GF, Shen HB. Epidemiologic differences in esophageal cancer between Asia and Western  populations.  Chi J Cancer. 2012;31(6):281-6. doi: 10.5732/cjc.011.10390. [PubMed: 22507220].
  11. Chattopadhyay I. A brief overview of genetics of esophageal squamous cell carcinoma. J Cell Sci Molecular Biol. 2014; 1(1):103.
  12. Roshandel G, Sadjadi A, Aarabi M, Keshtkar A, Sedaghat SM, Nouraie SM, et al. Cancer incidence in golestan province: report of an ongoing population-based cancer registry in Iran, 2004–2008. Arch Iran Med. 2012;15(4):196-200.
  13. Howlader N, Noone AM, Kerapcho M, Garshell J, Neyman N, Altekruse SF, et al. SEER cancer statistics review, 1974-2010. Bethesda: National Cancer Institute; 2013.
  14. Yarhosseini A, Sharifzadeh L, Delpisheh A, Veisani Y, Sayehmiri F, Sayehmiri K, et al. Survival rate of esophageal cancer in Iran- A systematic review and meta-analysis. Iran J Cancer Rev. 2014;7(2):61-5. [PubMed: 25250151].
  15. Mirinezhad SK, Somi MH, Jangjoo AG, Seyednezhad F, Dastgiri S, Mohammadzadeh M, et al. Survival rate and prognostic factors of esophageal cancer in east Azerbaijan. Asia Pac J Cancer Prev. 2012;13(7):3451-4. doi: 10.7314/apjcp.2012. 13.7.3451. [PubMed: 22994776].
  16. Samadi F, Babaei M, Yazdanbod A, Fallah M, Nouraie M, Nasrollahzadeh D, et al. Survival rate of gastric and esophageal cancers in Ardabil province, North-West of Iran. Arch Iran Med. 2007;10(1):32-7. doi: 07101/AIM.009. [PubMed: 17198451].
  17. Aghcheli K, Marjani HA, Nasorollahzadeh D, Islami F, Shakeri R, Sotoudeh M, et al. Prognostic factors for esophageal squamous cell carcinoma-- a population-based study in Golestan Province, Iran, a high incidence area. PLoS One. 2011; 6(7):e22152. doi: 10.1371/journal.pone.0022152. [PubMed: 21811567].
  18. Salek R, Warshoei F, Bezenjani SE, Saedi HS, Ashkiki MH, Hosainzadeh SM, et al. Chemoradiotherapy alone as the standard treatment of epidermoid esophageal carcinoma. Oncology. 2011;81(3-4):214-9. doi: 10.1159/000333448. [PubMed: 22075490].
  19. Anvari K, Aledavood SA, Toussi MS, Forghani MN, Mohtashami S, Rajabi MT, et al. A clinical trial of neoadjuvant concurrent chemoradiotherapy followed by resection for esophageal carcinoma. J Res Med Sci. 2015;20(8):751-6. doi: 10.4103/ 1735-1995.168377. [PubMed: 26664422].